EA
PRVA icon

Emerald Advisers’s Privia Health PRVA Stock Holding History

Emerald Advisers’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-321,325
Closed -$6.29M – 267
2024
Q1 		$6.29M Sell
321,325
-662,181
-67% -$14M 0.25% 112
2023
Q4 		$22.7M Buy
983,506
+74,648
+8% +$1.67M 0.97% 39
2023
Q3 		$20.9M Buy
908,858
+51,944
+6% +$1.32M 1.01% 35
2023
Q2 		$22.4M Buy
856,914
+30,870
+4% +$815K 0.98% 40
2023
Q1 		$22.8M Sell
826,044
-10,025
-1% -$265K 1.09% 32
2022
Q4 		$19M Buy
836,069
+389,615
+87% +$10.8M 0.92% 47
2022
Q3 		$15.2M Buy
+446,454
New +$16.5M 0.78% 55
2021
Q3 		– Sell
-186,920
Closed -$8.29M – 276
2021
Q2 		$8.29M Buy
+186,920
New +$6.9M 0.3% 109

Other funds holding PRVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Emerald Advisers's PRVA Position: Q2 2024 in Review

Emerald Advisers sold out of Privia Health (PRVA) in Q2 2024, closing a stake of 321,325 shares — an estimated $6.29M sold.

Emerald Advisers first reported a position in PRVA in Q2 2021 and held it in 8 quarters. The position peaked at $22.8M in Q1 2023. 225 funds tracked by Wall St. Rank hold PRVA as of Q2 2024.

  • Emerald Advisers reported no remaining Privia Health position as of Q2 2024 after selling out during the quarter.
  • Emerald Advisers sold 321,325 Privia Health shares in Q2 2024, an estimated $6.29M.
  • Emerald Advisers first reported a position in Privia Health in Q2 2021 and held it in 8 quarters.
  • Emerald Advisers's Privia Health position peaked at $22.8M in Q1 2023.
  • 225 funds tracked by Wall St. Rank held Privia Health as of Q2 2024.

Based on Emerald Advisers's 13F filing for Q2 2024, filed 6 Aug 2024.